0.9% Sodium chloride injection, USP; Solution bags leaking

Packaging

Date

2025-06-06

Country

Canada

Product

0.9% Sodium chloride injection, USP

Classification

Type I

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2025-06-10
2. CA
   Drugs & medicalType III

   Soframycin nasal spray; Out of specification (pH & benzalkonium chloride)

   Product quality

   Health CanadaOfficial notice →
3. CA
   Drugs & medicalType II

   Jamp-Hydralazine tablet: Affected lot may contain Jamp-Hydralazine 10 mg tablets

   Product safety

   Health CanadaOfficial notice →
4. 2025-06-06
5. CA
   Drugs & medicalType I

   Seasonique tablet; may be packaged with extra yellow tablets (ethinyl estradiol)

   Packaging

   Health CanadaOfficial notice →
6. CA
   Drugs & medicalType III

   Rivasa 81 mg EC tablet; Out of specification (salicylic acid impurity)

   Product quality

   Health CanadaOfficial notice →
7. 2025-06-05
8. CA
   Drugs & medicalType II

   VITROS® 4600, 5600 and 7600 Systems

   Performance

   Health CanadaOfficial notice →
9. CA
   Drugs & medicalType II

   Alinity I Total PSA Reagent Kit

   Performance

   Health CanadaOfficial notice →